Q2 2024 13F Holders as of 6/30/2024
-
Type / Class
-
Equity / NY ARCA BIOTECH
-
Number of holders
-
246
-
Total shares
-
3.46M
-
Shares change
-
-142K
-
Total reported value, excl. options
-
$533M
-
Value change
-
-$21.7M
-
Number of buys
-
83
-
Number of sells
-
-111
-
Price
-
$153.99
Significant Holders of FIRST TR EXCHANGE-TRADED FD - NY ARCA BIOTECH (FBT) as of Q2 2024
filings reported holding FBT - FIRST TR EXCHANGE-TRADED FD - NY ARCA BIOTECH as of Q2 2024.
FIRST TR EXCHANGE-TRADED FD - NY ARCA BIOTECH (FBT) has 246 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 3.46M shares
.
Largest 10 shareholders include MORGAN STANLEY (417K shares), WELLS FARGO & COMPANY/MN (373K shares), BANK OF AMERICA CORP /DE/ (243K shares), UBS Group AG (200K shares), LPL Financial LLC (199K shares), Royal Bank of Canada (181K shares), Berger Financial Group, Inc (152K shares), Raymond James Financial Services Advisors, Inc. (122K shares), RAYMOND JAMES & ASSOCIATES (80.2K shares), and COMMONWEALTH EQUITY SERVICES, LLC (53.5K shares).
This table shows the top 246 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.